Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Periodic Paralysis Panel Invitae United States | 18 | 6 |
|
PreventionGenetics, part of Exact Sciences United States | 177 | 163 |
|
Metabolic Myopathies, Rhabdomyolysis and Exercise Intolerance Panel PreventionGenetics, part of Exact Sciences United States | 106 | 83 |
|
Comprehensive Neuromuscular Panel PreventionGenetics, part of Exact Sciences United States | 183 | 142 |
|
Invitae Comprehensive Myopathy Panel Invitae United States | 143 | 70 |
|
Invitae Congenital Myopathy Panel Invitae United States | 58 | 36 |
|
Invitae Comprehensive Neuromuscular Disorders Panel Invitae United States | 353 | 208 |
|
Malignant Hyperthermia Susceptibility Panel PreventionGenetics, part of Exact Sciences United States | 5 | 3 |
|
RYR1-Related Congenital Myopathies via the RYR1 Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 57 | 41 |
|
Dyslipidemia and early atherosclerosis panel. 84-gene NGS panel. Genologica Medica Spain | 133 | 84 |
|
Metabolic myopathy and rhabdomyolysis panel. NGS panel of 52 genes. Genologica Medica Spain | 89 | 52 |
|
Skeletal diseases. NGS panel of 169 genes. Genologica Medica Spain | 373 | 169 |
|
Genologica Medica Spain | 172 | 59 |
|
Malignant Hyperthermia (NGS Panel and Copy Number Analysis) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 4 | 2 |
|
Asper Biogene Asper Biogene LLC Estonia | 7 | 3 |
|
CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 33 | 17 |
|
Neuromuscular Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 138 | 62 |
|
Comprehensive Metabolism NGS Panel Fulgent Genetics United States | 602 | 355 |
|
Fulgent Genetics United States | 186 | 61 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.